Why insider trading matters?
When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.
Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the development and advancement of treatments for dermatological and gastrointestinal indications. Edesa Biotech, Inc. has a collaborative research project with the National Research Council of Canada to develop novel immunotherapies for vitiligo, as well as other indications; and Light Chain Bioscience for the development and commercialization of two Phase 2-ready biologic drug candidates for various therapeutic, prophylactic, and diagnostic applications. The company was founded in 2015 and is headquartered in Markham, Canada.
| Trade Date | Insider | Title | Buy/Sell | #Shares | Price | Value | Option |
|---|---|---|---|---|---|---|---|
| 2020-03-29 | Nijhawan Pardeep | Chief Executive Officer | Buy | 2,000 | $5.23 | $10,460 | No |
| 2021-03-25 | Nijhawan Pardeep | Chief Executive Officer | Buy | 3,000 | $5.25 | $15,750 | No |
| 2021-03-25 | Brooks Michael J | President | Buy | 3,500 | $5.19 | $18,165 | No |
| 2021-03-24 | Brooks Michael J | President | Buy | 4,500 | $5.08 | $22,860 | No |
| 2021-03-24 | Nijhawan Pardeep | Chief Executive Officer | Buy | 5,000 | $5.16 | $25,800 | No |
| 2021-02-18 | OAKES FRANK R. | Director | Sell | 7,992 | $7.25 | $57,942 | No |
| 2020-05-27 | Brooks Michael J | President | Buy | 2,500 | $3.00 | $7,498 | No |
| 2020-05-26 | Nijhawan Pardeep | Chief Executive Officer | Buy | 3,000 | $2.98 | $8,939 | No |
| 2020-03-17 | Nijhawan Pardeep | Chief Executive Officer | Buy | 5,000 | $1.87 | $9,373 | No |
| 2020-01-08 | van der Velden Peter | 10%-Owner, Director | Buy | 140,625 | $3.20 | $450,000 | Yes |
| 2020-01-08 | Sistilli Carlo | Director | Buy | 2,436 | $4.11 | $10,012 | Yes |
| 2020-01-08 | JOHNSON LORIN K | Director | Buy | 8,524 | $4.11 | $35,034 | Yes |
| 2020-01-08 | Brooks Michael J | President | Buy | 1,827 | $4.11 | $7,509 | Yes |
| 2019-09-11 | OAKES FRANK R. | Director | Sell | 1,809 | $5.72 | $10,345 | No |
| 2019-03-06 | OAKES FRANK R. | President & CEO | Sell | 4,000 | $1.25 | $5,000 | No |
| 2018-10-12 | MORSE DANIEL E. | Former Director | Sell | 7,047 | $1.31 | $9,260 | No |
| 2018-10-12 | OAKES FRANK R. | President & CEO | Sell | 3,000 | $1.31 | $3,930 | No |
| 2018-03-29 | MORSE DANIEL E. | Director | Sell | 4,366 | $0.81 | $3,515 | No |
| 2018-03-12 | MORSE DANIEL E. | Director | Sell | 32,300 | $0.79 | $25,600 | Yes |
Insider Smart
Insider Smart